- Exact Sciences Stock, A Cathie Wood’s Play, Surges On Freenome’s Pale Results Investor’s Business Daily
- Opinion | Too few people are screened for colon cancer. This new test might help. The Washington Post
- Freenome Announces Topline Results for PREEMPT CRC® to Validate the First Version of its Blood-Based Test for the Early Detection of Colorectal Cancer PR Newswire
- New blood test shows high accuracy for colorectal cancer detection, study finds: ‘Not interchangeable’ Fox News
- Citi sees Exact Sciences shares climbing after rival’s data disappoints Investing.com India
Tag Archives: investors
Charlie Munger’s Final Advice For Investors Is About Embracing Value In Unlikely Places: ‘If Something Is Really Cheap, Even Though It’s A Crappy Company, I’m Willing To Consider Buying It’ – Yahoo Finance
- Charlie Munger’s Final Advice For Investors Is About Embracing Value In Unlikely Places: ‘If Something Is Really Cheap, Even Though It’s A Crappy Company, I’m Willing To Consider Buying It’ Yahoo Finance
- Billionaire Charlie Munger wanted his kids to hold onto 3 parenting lessons ‘until their 100th birthdays’ CNBC
- Remembering Charlie Munger | Market Masters With Mohnish Pabrai | N18L | CNBC TV18 CNBC-TV18
- Opinion | The Timeless Investing Wisdom of Charlie Munger, Buffett’s No. 2 The New York Times
- Munger, Kissinger and the American Century Kathimerini English Edition
Charlie Munger Says Investors Have To Buy These Stocks ‘To Get Ahead’ – Seeking Alpha
- Charlie Munger Says Investors Have To Buy These Stocks ‘To Get Ahead’ Seeking Alpha
- Charlie Munger Calls It Overhyped, but Buffett Owns Billions: Warren’s 3 Big AI Stock Bets InvestorPlace
- Legendary investor Charlie Munger blasted gamblers, touted Heinz and Hermès, and revealed Warren Buffett’s views in a rare interview this week. Here are his 22 best quotes. Yahoo Finance
- Berkshire Vice Chair Charlie Munger Compares Bitcoin to a ‘Stink Ball’ Among Traditional Currencies – Featured Bitcoin News Bitcoin.com News
- Charlie Munger Expresses Concern Over Bitcoin’s Rise Cryptonews
- View Full Coverage on Google News
‘Bond King’ Jeffrey Gundlach warns higher-for-longer interest rates could trigger the next Financial Crisis—and advises investors to ‘T-Bill and Chill’ – Yahoo Finance
- ‘Bond King’ Jeffrey Gundlach warns higher-for-longer interest rates could trigger the next Financial Crisis—and advises investors to ‘T-Bill and Chill’ Yahoo Finance
- Layoffs are coming, warns DoubleLine CEO Jeffrey Gundlach CNBC Television
- DoubleLine’s Gundlach says interest rates are going to fall as recession arrives early 2024 CNBC
- Layoffs are coming with a US recession looming, Jeff Gundlach warns Business Insider
- Gundlach says ‘massive interest-expense problem’ could cause next U.S. crisis MarketWatch
- View Full Coverage on Google News
FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company – Investors | Eli Lilly and Company
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company Investors | Eli Lilly and Company
- Lilly’s bowel disease drug gets US FDA nod for treatment in adults Reuters
- FDA approves Eli Lilly ulcerative colitis treatment Omvoh – STAT STAT
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis PR Newswire
- FDA Approves Lilly’s Omvoh™ (mirikizumab-mrkz), A First-in-Class Treatment for Adults with Moderately to Severely Active Ulcerative Colitis Yahoo Finance
- View Full Coverage on Google News
Dow Jones Futures Fall As 10-Year Treasury Yield Tops 5%; Microsoft, Meta Lead Earnings Wave – Investor’s Business Daily
- Dow Jones Futures Fall As 10-Year Treasury Yield Tops 5%; Microsoft, Meta Lead Earnings Wave Investor’s Business Daily
- Meta, Alphabet, Amazon, Microsoft highlight earnings barrage: What to know this week Yahoo Finance
- Big-tech results will decide ‘where we go from here’ amid investor caution. They would fall if it weren’t for this one company MarketWatch
- Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings Barchart
- Strong ad sales, stable enterprise spending wind beneath Big Tech earnings Reuters
- View Full Coverage on Google News
Dow Jones Rises On Q3 Earnings Results; Netflix Slides On Downgrade – Investor’s Business Daily
- Dow Jones Rises On Q3 Earnings Results; Netflix Slides On Downgrade Investor’s Business Daily
- Dow rises 200 points, heads for winning week after strong bank earnings, yields retreat: Live updates CNBC
- US futures steady as big banks kick off earnings season: Stock market news today Yahoo Finance
- Q3 Earnings Season Poses Next Big Test for S&P 500: Here’s How to Prepare for It | investing.com Investing.com
- Analysts’ outlook of another quarterly profit drop is bad for stocks. But they’re routinely wrong The Associated Press
- View Full Coverage on Google News
Bullish investors positioned well for earnings season, says Tim Seymour – CNBC Television
- Bullish investors positioned well for earnings season, says Tim Seymour CNBC Television
- Hollywood and Netflix are in a tight spot, says Deepwater Asset Management’s Gene Munster CNBC Television
- GM seems most vulnerable due to low supply of some popular vehicles: AutoTrader.com’s Brian Moody CNBC Television
- Crypto industry needs more and more regulation, says FTX creditor Bhagamshi Kannegundla CNBC Television
- Make It Mondays: Entrepreneur builds luxury chicken coops into more than $2 million business CNBC Television
- View Full Coverage on Google News
AKRO Stock Plummets, Dragging Down ETNB Stock, On Liver-Disease Flop – Investor’s Business Daily
- AKRO Stock Plummets, Dragging Down ETNB Stock, On Liver-Disease Flop Investor’s Business Daily
- Akero Therapeutics to Present Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis Due to NASH Yahoo Finance
- Biggest stock movers today: Coherent, Truist Financial, Akero Therapeutics and more (COHR) Seeking Alpha
- Akero’s stock sinks as midphase cirrhosis fail sparks flash NASH crash FierceBiotech
- Akero Therapeutics, Palantir, Hyatt Hotels: Trending tickers Yahoo Finance
- View Full Coverage on Google News
Dow Jones Slides 250 Points On Key Housing Data; DraftKings Pops On Upgrade – Investor’s Business Daily
- Dow Jones Slides 250 Points On Key Housing Data; DraftKings Pops On Upgrade Investor’s Business Daily
- WEDNESDAY’S BLOG Stock Market Today: What to Watch The Wall Street Journal
- NASDAQ 100, Dow Jones, S&P 500 News: Market Braces for October’s Volatility Amid Rate, Political Concerns FX Empire
- Stock Market Tests August Lows But These Indicators Remain Bearish; Yield Hits Nearly 16-Year High Investor’s Business Daily
- Nasdaq, S&P 500 Futures Retreat On Rate-Hike Worries — But Here’s Why This Analyst Sees Bullish End To Ye Benzinga
- View Full Coverage on Google News